These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7723585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Caramiphen: a non-opioid antitussive with potent anticonvulsant properties in rats.
    Tortella FC, Witkin JM, Musacchio JM.
    Eur J Pharmacol; 1988 Oct 11; 155(1-2):69-75. PubMed ID: 3243332
    [Abstract] [Full Text] [Related]

  • 3. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices.
    Thurgur C, Church J.
    Br J Pharmacol; 1998 Jul 11; 124(5):917-29. PubMed ID: 9692777
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site.
    Hudkins RL, Mailman RB, DeHaven-Hudkins DL.
    Eur J Pharmacol; 1994 Dec 12; 271(1):235-6. PubMed ID: 7698207
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and evaluation of 3-substituted 17-methylmorphinan analogs as potential anticonvulsant agents.
    Newman AH, Bevan K, Bowery N, Tortella FC.
    J Med Chem; 1992 Oct 30; 35(22):4135-42. PubMed ID: 1433216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
    Ucar H, Cacciaguerra S, Spampinato S, Van derpoorten K, Isa M, Kanyonyo M, Poupaert JH.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):267-73. PubMed ID: 9369382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents.
    Calderon SN, Newman AH, Tortella FC.
    J Med Chem; 1991 Nov 24; 34(11):3159-64. PubMed ID: 1956032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures.
    Upton N, Blackburn TP, Campbell CA, Cooper D, Evans ML, Herdon HJ, King PD, Ray AM, Stean TO, Chan WN, Evans JM, Thompson M.
    Br J Pharmacol; 1997 Aug 24; 121(8):1679-86. PubMed ID: 9283703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents.
    Pontecorvo MJ, Karbon EW, Goode S, Clissold DB, Borosky SA, Patch RJ, Ferkany JW.
    Brain Res Bull; 1991 Mar 24; 26(3):461-5. PubMed ID: 1646668
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile.
    Tortella FC, Robles L, Witkin JM, Newman AH.
    J Pharmacol Exp Ther; 1994 Feb 24; 268(2):727-33. PubMed ID: 8113984
    [Abstract] [Full Text] [Related]

  • 20. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
    Nguyen VH, Kassiou M, Johnston GA, Christie MJ.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):233-40. PubMed ID: 8891604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.